ArticlePediatric cardiology2025
Comment on "Contraception Use in Adolescents and Young Adults with Congenital Heart Disease".
Article in Pediatric cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contraceptive use among adolescents and young adults with congenital heart disease (CHD) is notably lower, influenced by multiple critical factors. This critique highlights three key determinants that warrant further investigation in future research. First, studies indicate that hormonal contraceptives, particularly estrogen-containing methods, may elevate the risk of thromboembolic complications, arrhythmias, and heart failure in CHD patients, especially those with Fontan circulation or transposition of the great arteries. Second, menstrual irregularities are prevalent among CHD patients, with a significant proportion facing contraindications to estrogen-based contraceptives, potentially discouraging their use. Lastly, inadequate disease-specific contraceptive counseling contributes to knowledge gaps, limiting informed decision-making regarding reproductive health. Addressing these determinants is essential to optimize contraceptive use and improve reproductive health outcomes in CHD patients.
Indexed as
Identifiers
40119071What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.